Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New Designer Drugs.

Michael Levine1, Frank Lovecchio2

  • 1Department of Emergency Medicine, University of California, Los Angeles, 924 Westwood Boulevard Suite 300, Los Angeles, CA 90095, USA.

Emergency Medicine Clinics of North America
|July 3, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Response to Trametinib in Central Giant Cell Granuloma With <i>KRAS</i> Gain-of-Function Mutation: A Case Report.

JCO precision oncology·2026
Same author

COMMENTARY.

Annals of emergency medicine·2026
Same author

Levamisole in opioid overdose patients: An evolving adulterant landscape.

Addictive behaviors·2026
Same author

Interpreting Fentanyl and Norfentanyl Concentrations among Patients Seen in the Emergency Department after a Nonfatal Opioid Overdose: A Multicenter Study.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Commentary on Schettino et al.: Distinguishing psychological support from psychotherapy in psychedelic medicine - Integrating intent and behavioral frameworks.

General hospital psychiatry·2026
Same author

Illicit opioid adulterant trends in patients presenting with acute opioid overdose.

Journal of analytical toxicology·2026
Same journal

Why Dispelling Myths and Misconceptions in Emergency Medicine Matters.

Emergency medicine clinics of North America·2026
Same journal

Myths and Misconceptions in Emergency Medicine.

Emergency medicine clinics of North America·2026
Same journal

Acute Otitis Media-Watch and Wait Is Not a Myth.

Emergency medicine clinics of North America·2026
Same journal

Hot or Not? Myths and Misconceptions About Antipyretics for Pediatric Fever.

Emergency medicine clinics of North America·2026
Same journal

Epinephrine Improves Outcomes in Out-Of-Hospital Cardiac Arrests.

Emergency medicine clinics of North America·2026
Same journal

Myth: Pretreatment Prevents Intravenous Contrast Reactions in the Emergency Department.

Emergency medicine clinics of North America·2026
See all related articles

This article reviews emerging novel drugs, including opioids like buprenorphine and fentanyl, and other substances such as kratom, etizolam, phenibut, phenethylamines, and marijuana, highlighting potential toxicities in adolescents and adults.

Area of Science:

  • Pharmacology
  • Toxicology
  • Public Health

Background:

  • The rise of novel psychoactive substances presents challenges in identifying and managing drug toxicity.
  • Opioid epidemic continues to evolve with new synthetic and plant-derived compounds.
  • Adolescents and adults are susceptible to the adverse effects of emerging drugs.

Purpose of the Study:

  • To provide an overview of emerging drugs and their associated toxicities.
  • To discuss the evolving landscape of the opioid epidemic.
  • To cover a range of substances including opioids, sedatives, and novel compounds.

Main Methods:

  • Literature review of emerging drugs and their toxicological profiles.
  • Discussion of clinical implications and public health concerns.
Keywords:
Novel drugsOpiatesOverdosePhenethylamineToxicology

Related Experiment Videos

  • Synthesis of information on substances like buprenorphine, fentanyl, kratom, etizolam, phenibut, phenethylamines, and marijuana.

    • Main Results:

    • Emergence of diverse novel drugs necessitates updated clinical awareness.
    • Opioid derivatives and other novel substances pose significant toxicity risks.
    • Understanding the pharmacology of these agents is crucial for effective treatment.

    Conclusions:

    • Healthcare providers must be aware of emerging drug trends and potential toxicities.
    • Public health strategies are needed to address the risks associated with novel psychoactive substances.
    • Continued research is essential to understand and mitigate the harms of new drugs.